A Novel Diagnostic Biomarker, PZP, for Detecting Colorectal Cancer in Type 2 Diabetes Mellitus Patients Identified by Serum-Based Mass Spectrometry

Background: Growing evidence has confirmed that populations with type 2 diabetes mellitus (T2DM) have an increasing risk of developing colorectal cancer (CRC). Thus, convenient and effective screening strategies for CRC should be developed for the T2DM population to increase the detection rate of CR...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jiayue, Fang, Weigang, Wu, Wenjun, Tian, Zhen, Gao, Rong, Yu, Lu, Chen, Dayang, Weng, Xiaohua, Zhu, Shengwei, Yang, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670180/
https://www.ncbi.nlm.nih.gov/pubmed/34917649
http://dx.doi.org/10.3389/fmolb.2021.736272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670180/
https://www.ncbi.nlm.nih.gov/pubmed/34917649
http://dx.doi.org/10.3389/fmolb.2021.736272

Ejemplares similares